NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹230 Cr | ₹102 Cr | ₹198 Cr | ₹161 Cr | ₹76 Cr |
What is the latest Contingent Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹230 Cr |
| Mar2025 | ₹102 Cr |
| Mar2024 | ₹198 Cr |
| Mar2023 | ₹161 Cr |
| Mar2022 | ₹76 Cr |
How is Contingent Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹230 Cr | 125.14 | |
| Mar2025 | ₹102 Cr | -48.56 | |
| Mar2024 | ₹198 Cr | 22.75 | |
| Mar2023 | ₹161 Cr | 113.41 | |
| Mar2022 | ₹76 Cr | - | |
Compare Contingent Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹243.7 Cr | 7% | 9.4% | -28.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 7% |
9.4% |
-28.7% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses